EAN 2021 | Personalized medicine: an important step in the management of MS

Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, explains how treatment for multiple sclerosis may be personalized and the benefits of doing so. Available treatments vary in terms of their benefits and side effects; personalized treatment is essential for optimal treatment selection. Personalization takes into account biomarkers, such as blood markers and prognosis factors, including age and comorbidities. It also considers the expectations of the patient and their preferences, this is important to ensure patient cooperation and therefore to improve treatment efficacy. It is important to note that treatment may evolve with the changing circumstances of the patient. This interview took place during the European Academy of Neurology 2021 congress.